VIVAKOR INC (VIVK)       1.12  +0.03 (+2.76%)

1.12  +0.03 (+2.76%)

US92852R4039 - Common Stock - After market: 1.03 -0.09 (-8.04%)


Fundamental Rating

1

Overall VIVK gets a fundamental rating of 1 out of 10. We evaluated VIVK against 99 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of VIVK have multiple concerns. VIVK has a expensive valuation and it also scores bad on growth

Note: VIVK has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

0

VIVK has a very weak Piotroski-F score of 1.00. This is an indication of health and profitability issues for VIVK.

VS Industry

Valuation

Valuation Rating

3

When comparing the current price to the book value of VIVK, it is valued rather cheaply. It is trading at 0.66 times its book value.
Compared to an average industry price book ratio of 1.93, VIVK is valued rather cheaply. On top of this, VIVK is cheaper than 90% of the companies listed in the same industry.

VIVK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VS Industry

Price/Book (0.66) VS Industry: 90% outperformed.

43.97
0.14

Growth

Growth Rating

2

Measured over the past 5 years, VIVK shows a very strong growth in Revenue. The Revenue has been growing by 374.63% on average per year.
VIVK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.89%.

Looking at the last year, VIVK shows a very negative growth in Revenue. The Revenue has decreased by -25.34% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -101.89% N/A N/A N/A N/A
RevenueN/A 374.63% -25.34% N/A N/A N/A N/A

Health

Health Rating

1

A Current Ratio of 1.08 indicates that VIVK should not have too much problems paying its short term obligations.
A Quick Ratio of 1.06 indicates that VIVK should not have too much problems paying its short term obligations.
When comparing the Current Ratio of VIVK to the average industry Current Ratio of 1.32, VIVK is less able to pay its short term obligations than its industry peers.
Compared to an average industry Quick Ratio of 1.13, VIVK is worse placed to pay its short term obligations than its industry peers.

When comparing the Debt to Equity Ratio of VIVK to the average industry Debt to Equity Ratio of 0.55, VIVK required more debt to finance its operations than its industry peers.
Based on the Altman-Z score of -0.81, we must say that VIVK is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 1.94, VIVK is in worse financial state than most of its industry peers. 88% of its industry peers have a better Altman-Z score.
The Piotroski-F score of VIVK is 1.00. This is a very weak score and indicates problems in health and profitability for VIVK.
VS Industry

Debt/Equity (1.23) VS Industry: 28% outperformed.

16.13
0.00

Quick Ratio (1.06) VS Industry: 40% outperformed.

0.02
40.95

Current Ratio (1.08) VS Industry: 28% outperformed.

0.02
40.95

Altman-Z (-0.81) VS Industry: 12% outperformed.

-39.85
28.77

Dividend

Dividend Rating

0

VIVK does not give a dividend.

VIVAKOR INC1.12

NASDAQ:VIVK (1/27/2023, 7:00:02 PM)+0.03 (+2.76%)

After market: 1.03 -0.09 (-8.04%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Commercial Services & Supplies
Earnings (Last) 11-21 2022-11-21/bmo Earnings (Next) N/A N/A
Inst Owners N/A Inst Owner Change N/A
Ins Owners 23.24% Ins Owner Change 0%
Market Cap 20.23M Analysts N/A
Price Target N/A

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) N/A EPS NQ rev (1m) N/A
EPS NY rev (1m) N/A Revenue NQ rev (1m) N/A
Revenue NY rev (1m) N/A

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM) -0.92 EY N/A
EPS(NY) N/A Fwd EY N/A
FCF(TTM) N/A FCFY N/A
OCF(TTM) N/A OCFY N/A
SpS 0.71 BVpS 1.69
TBVpS -0.87 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 9.73%
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y -62.38% GM growth 5Y N/A
F-Score 1 Asset Turnover 0.14

Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.06
Altman-Z -0.81
F-Score 1 WACC 8.75%
ROIC/WACC N/A Cap/Depr(3y) 168.86%
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -101.89% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q N/A
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y -25.34% Revenue growth 3Y 374.63%
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y -42.85% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year N/A
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y -150.81% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -65.47%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA